Technical Analysis for TRIL - Trillium Therapeutics Inc

Grade Last Price % Change Price Change
grade D 0.35 12.98% 0.0402
TRIL closed up 12.98 percent on Monday, September 9, 2019, on 1.73 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A N/A
See historical TRIL trend table...

Date Alert Name Type % Chg
Gapped Up Strength 0.00%
New 52 Week Closing Low Bearish 12.98%
Hot IPO Pullback Bullish Swing Setup 12.98%
NR7 Range Contraction 12.98%
New 52 Week Low Weakness 12.98%
Gapped Down Weakness 12.98%
Hot IPO Pullback Bullish Swing Setup -80.23%
New 52 Week Low Weakness -80.23%
Outside Day Range Expansion -80.23%
New 52 Week Closing Low Bearish -78.66%

Older signals for TRIL ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Trillium Therapeutics Inc., a clinical-stage immuno-oncology company, develops therapies for the treatment of cancer. The company's lead program is TTI-621, a SIRPaFc fusion protein that acts a soluble decoy receptor preventing CD47 from delivering its inhibitory signal, which is in Phase I clinical trial for advanced hematologic malignancies, and solid tumors and mycosis fungoides. Its product candidates also include TTI-622, an IgG4 SIRPaFc protein for combination therapy; and epidermal growth factor receptor antagonist, which is in preclinical development stage, as well as undisclosed immuno-oncology targets that are in the discovery Phase. The company was formerly known as Stem Cell Therapeutics Corp. and changed its name to Trillium Therapeutics Inc. in June 2014. Trillium Therapeutics Inc. was founded in 2004 and is headquartered in Mississauga, Canada.
Medicine Medical Specialties Cancer Organ Systems Treatment Of Cancer Solid Tumors Cancer Immunotherapy
Is TRIL a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 6.0718
52 Week Low 0.2899
Average Volume 273,536
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 0.0
10-Day Moving Average 0.0
Average True Range 0.0
ADX 0.0
+DI 0.0
-DI 0.0
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.0
Lower Bollinger Band 0.0
Percent B (%b) 0.0
BandWidth 0.0
MACD Line 0.0
MACD Signal Line 0.0
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.4591
Resistance 3 (R3) 0.4703 0.4451 0.4409
Resistance 2 (R2) 0.4451 0.4174 0.4395 0.4348
Resistance 1 (R1) 0.3976 0.4002 0.3850 0.3864 0.4288
Pivot Point 0.3724 0.3724 0.3662 0.3668 0.3724
Support 1 (S1) 0.3249 0.3447 0.3123 0.3137 0.2712
Support 2 (S2) 0.2997 0.3275 0.2941 0.2652
Support 3 (S3) 0.2522 0.2997 0.2591
Support 4 (S4) 0.2410